Expertise in
13
conditions

Dr. Zain A. Husain

Radiation Oncology
Southern California Permanente Medical Group
9961 Sierra Ave, 
Fontana, CA 
Expertise in
13
conditions
Southern California Permanente Medical Group
9961 Sierra Ave, 
Fontana, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Zain Husain is a Radiation Oncologist in Fontana, California. Dr. Husain is highly rated in 13 conditions, according to our data. His top areas of expertise are Adenoid Cystic Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Acinic Cell Carcinoma of Salivary Glands, Pleuropulmonary Blastoma, and Gastrostomy.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in CT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D

Locations

SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
9961 Sierra Ave, Fontana, CA 92335
Other Locations
SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
2295 S Vineyard Ave, Ontario, CA 91761

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation
A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation
Enrollment Status: Terminated
Publish Date: July 29, 2025
Intervention Type: Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Completed
Publish Date: June 10, 2022
Intervention Type: Drug, Other, Radiation, Biological
Study Drugs: Cisplatin, Pembrolizumab
Study Phase: Phase 1
A Window Study to Assess the Activity of Demethylation Therapy in Patients With HPV-Positive Compared With HPV-Negative Head and Neck Squamous Cell Carcinoma, With Response Assessment and Biomarker Expansion Cohort in HPV-Positive Oropharynx Cancer
A Window Study to Assess the Activity of Demethylation Therapy in Patients With HPV-Positive Compared With HPV-Negative Head and Neck Squamous Cell Carcinoma, With Response Assessment and Biomarker Expansion Cohort in HPV-Positive Oropharynx Cancer
Enrollment Status: Completed
Publish Date: February 15, 2022
Intervention Type: Drug
Study Drug: 5-Azacitadine
Study Phase: Phase 1
View 4 Less Clinical Trials

134 Total Publications

Fractionated radiotherapy for vestibular schwannoma.
Fractionated radiotherapy for vestibular schwannoma.
Journal: Handbook of clinical neurology
Published: October 06, 2025
Similar Doctors
Expertise in
32
conditions
Dr. Arya R. Amini
Radiation Oncology
Expertise in
32
conditions
Dr. Arya R. Amini
Radiation Oncology

City Of Hope Medical Foundation

1500 E Duarte Rd, 
Duarte, CA 
 (31.0 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arya Amini is a Radiation Oncologist in Duarte, California. Dr. Amini is highly rated in 32 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Penectomy, and Nephrectomy.

Expertise in
21
conditions
Dr. Mitchell R. Kamrava
Radiation Oncology
Expertise in
21
conditions
Dr. Mitchell R. Kamrava
Radiation Oncology

Cedars-Sinai Medical Center

8700 Beverly Blvd, 
West Hollywood, CA 
 (54.1 miles away)
310-423-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mitchell Kamrava is a Radiation Oncologist in West Hollywood, California. Dr. Kamrava is highly rated in 21 conditions, according to our data. His top areas of expertise are Cervical Cancer, Vaginal Cancer, Prostate Cancer, Prostatectomy, and Vitrectomy.

Expertise in
29
conditions
Dr. Percy P. Lee
Radiation Oncology
Expertise in
29
conditions
Dr. Percy P. Lee
Radiation Oncology

City Of Hope Medical Foundation

1601 Avocado Ave, 
Newport Beach, CA 
 (40.2 miles away)
949-763-2204
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Percy Lee is a Radiation Oncologist in Newport Beach, California. Dr. Lee is highly rated in 29 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Anal Cancer, and Liver Embolization.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Husain's expertise for a condition
ConditionClose
      View All 13 Advanced Conditions
      View All 49 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile